Corporate News 05-Jul-22
Biocon Biologics receives EU GMP certificate for new facility in Bengaluru
Biocon announced that its subsidiary, Biocon Biologics has received a EU GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru, following a GMP inspection in April 2022.
Previous News
Biocon consolidated net profit rises 550.59% in the June 2024 quarter
( Results - Announcements 09-Aug-24 07:32 )
Biocon jumps after receiving SAHPRA approval for Tacrolimus capsules
( Hot Pursuit - 22-Apr-24 11:39 )
Biocon arm gets USFDA nod for chronic heart failure drug
( Hot Pursuit - 02-Sep-24 08:59 )
Board of Biocon recommends final dividend
( Corporate News - 16-May-24 17:54 )
Biocon Ltd spurts 1.83%, gains for third straight session
( Hot Pursuit - 22-Mar-24 13:05 )
Biocon to hold board meeting
( Corporate News - 11-Apr-24 16:18 )
Biocon's subsidiary receives UK’s MHRA approval for Aflibercept biosimilar
( Hot Pursuit - 13-Nov-23 17:05 )
Biocon gains after subsidiary secures 'Yesafili' entry into Canadian market
( Hot Pursuit - 04-Mar-24 11:42 )
Biocon Ltd eases for fifth straight session
( Hot Pursuit - 25-Oct-23 13:35 )
Biocon to declare Quarterly Result
( Corporate News - 10-Oct-23 11:29 )
Biocon Biologics divests its non-crore branded formulations biz in India
( Corporate News - 10-Nov-23 12:06 )
Other Stories
ITD Cementation India wins order of Rs 1,937 cr
03-Oct-24 10:35
NIIT Learning Systems allots 1,666 equity shares under ESOP
03-Oct-24 10:30
Ashoka Metcast to discuss results
03-Oct-24 10:29
Emerald Finance to declare Quarterly Result
03-Oct-24 10:29
Rhetan TMT schedules board meeting
03-Oct-24 10:29
Shrenik to table results
03-Oct-24 10:29
Universal Arts to declare Quarterly Result
03-Oct-24 10:28
Three M Paper Boards to conduct board meeting
03-Oct-24 10:28
Arkade Developers to declare Quarterly Result
03-Oct-24 10:28
Worth Investment & Trading Company announces board meeting date
03-Oct-24 10:28
Back
Top